NYSE
-$0.47
(-0.38%)
Subscribe to get
AI Score
Glenmede Trust Co. NA decreased its holdings in PTC Inc. (NASDAQ:PTC – Free Report) by 11.1% in the third quarter, according to its most recent filing with the Securities and Exchange Commission ...
PTC Inc PTC has teamed up with Microsoft MSFT and Volkswagen Group VWAGY to create the Codebeamer...
PTC Therapeutics (NASDAQ:PTCT – Get Free Report) had its price target raised by investment analysts at UBS Group from $47.00 to $71.00 in a report issued on Tuesday,Benzinga reports. The brokerage ...
PTC Therapeutics (NASDAQ:PTCT – Get Free Report) was upgraded by equities researchers at Royal Bank of Canada from a “sector perform” rating to an “outperform” rating in a research note issued ...
UBS raised the firm’s price target on PTC Therapeutics (PTCT) to $71 from $47 and keeps a Buy rating...
On Monday, PTC Therapeutics, Inc. (NASDAQ:PTCT) signed an exclusive global license and collaboration...
Following this transaction, the insider now owns 47,282 shares of PTC Inc. PTC Inc (PTC) is a global software and services company that provides technology solutions to help companies design ...
Healthcare of Ontario Pension Plan Trust Fund bought a new position in shares of PTC Inc. (NASDAQ:PTC – Free Report) in the third quarter, according to its most recent 13F filing with the Securities ...
Shares of PTC Therapeutics surged Monday when the pharmaceutical firm announced it struck a nearly...
On Monday, PTC Therapeutics, Inc. (NASDAQ: NASDAQ:PTCT) saw its shares surge by 20% following the...